Triterpenoid–PEG Ribbons Targeting Selectivity in Pharmacological Effects
Authors:
- Zulal ÖzdemirZÖZulal Özdemir
- Uladzimir BildziukevichUBUladzimir Bildziukevich
- Martina ČapkováMČMartina Čapková
- Petra LoveckáPLPetra Lovecká
- Lucie RárováLRLucie Rárová
- David ŠamanDŠDavid Šaman
- Michala ZgarbováMZMichala Zgarbová
- Barbora LapuníkováBLBarbora Lapuníková
- Jan WeberJWJan Weber
- Oxana KazakovaOKOxana Kazakova
- Zdeněk WimmerZdeněk Wimmer
Open Access
- 3 August 2021
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 9 (8) , 951
Abstract
(1) Background: To compare the effect of selected triterpenoids with their structurally resembling derivatives, designing of the molecular ribbons was targeted to develop compounds with selectivity in their pharmacological effects. (2) Methods: In the synthetic procedures, Huisgen 1,3-dipolar cycloaddition was applied as a key synthetic step for introducing a 1,2,3-triazole ring as a part of a junction unit in the molecular ribbons. (3) Results: The antimicrobial activity, antiviral activity, and cytotoxicity of the prepared compounds were studied. Most of the molecular ribbons showed antimicrobial activity, especially on Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecalis, with a 50–90% inhibition effect (c = 25 µg·mL−1). No target compound was effective against HSV-1, but 8a displayed activity against HIV-1 (EC50 = 50.6 ± 7.8 µM). Cytotoxicity was tested on several cancer cell lines, and 6d showed cytotoxicity in the malignant melanoma cancer cell line (G-361; IC50 = 20.0 ± 0.6 µM). Physicochemical characteristics of the prepared compounds were investigated, namely a formation of supramolecular gels and a self-assembly potential in general, with positive results achieved with several target compounds. (4) Conclusions: Several compounds of a series of triterpenoid molecular ribbons showed better pharmacological profiles than the parent compounds and displayed certain selectivity in their effects.Keywords
Funding Information
- Ministerstvo Průmyslu a Obchodu (FV30300)
- European Regional Development Fund (CZ.02.1.01/0.0/0.0/16_019/0000738)
This publication has 49 references indexed in Scilit:
- Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP–1B: In vitro, in silico, and in vivo approachesEuropean Journal of Medicinal Chemistry, 2011
- Pentacyclic Triterpene Distribution in Various Plants – Rich Sources for a New Group of Multi-Potent Plant ExtractsMolecules, 2009
- Synthesis of olean-18(19)-ene derivatives from betulinRussian Journal of Bioorganic Chemistry, 2009
- Antibacterial and Antiparasitic Activity of Oleanolic Acid and its Glycosides isolated from Marigold (Calendula officinalis)Planta Medica, 2008
- Oleanolic acid enhances insulin secretion in pancreatic β‐cellsFEBS Letters, 2008
- Anti-Inflammatory Triterpenes from Pistacia terebinthus GallsPlanta Medica, 2002
- Anti-AIDS Agents. 30. Anti-HIV Activity of Oleanolic Acid, Pomolic Acid, and Structurally Related TriterpenoidsJournal of Natural Products, 1998
- Anti-inflammatory activity of oleanolic acid in rats and miceJournal of Pharmacy and Pharmacology, 1992
- Moronic Acid, a Simple Triterpenoid Keto Acid with Antimicrobial Activity Isolated from Ozoroa mucronata1Planta Medica, 1979
- MOROLIC ACID, A TRITERPENOID SAPOGENINJournal of the American Chemical Society, 1950